Reputable Apple leaker Sonny Dickson shared a first look at a prototype pair of Powerbeats Pro 2 in a transparent colorway. Apple initially debuted the Powerbeats Pro 2 back in February ...

US-based biopharmaceutical company Connect Biopharma has begun a Phase II trial to assess the efficacy and safety of rademikibart in treating acute exacerbations of asthma and type II inflammation.

"The initiation of our second Phase 2 study in patients with inflammatory lung disease highlights our commitment to swiftly advancing the development of rademikibart for asthma and COPD,” said Barry ...

Connect Biopharma Holdings Limited has announced the initiation of its Phase 2 Seabreeze STAT Asthma study, which aims to evaluate the safety and efficacy of rademikibart in treating acute ...

SAN DIEGO - Connect Biopharma Holdings Limited (NASDAQ:CNTB), a biopharmaceutical company valued at $44.83 million, announced the commencement of its Phase 2 Seabreeze STAT Asthma study following ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. As Thunderbolts* rolls out to theaters this weekend, Phase 5 of the Marvel Cinematic ...

DARPA has announced a major shift in the final phase of its NOM4D program, transitioning from laboratory testing to small-scale orbital demonstrations. This move aims to evaluate novel materials ...

The announcement from Phase Connect clarified that Saya may still appear in some activities. It confirmed she will be in music videos and “other groupworks.” The company also noted her YouTube ...

With a commanding lead over the global EV battery market, CATL now has a new target as it looks to phase out gas-powered vehicles. CATL announced plans to roll out 1,000 EV battery swap stations ...

It is only on January 27 next year when all dealers will be ready to showcase the Kylaq at their showrooms and get ready for customers, demo cars for test drives. For Petr Janeba, December 2 is ...

Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients' kidney function in a phase 2 trial. Investigators now have ...